[
  {
    "ts": null,
    "headline": "AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024",
    "summary": "Amgen (NASDAQ:AMGN) today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., Nov. 14-19, 2024. New data showcase reduction in disease activity by UPLIZNA® (inebilizumab-cdon) in Immunoglobulin G4-Related Disease (IgG4-RD) and support shorter infusion times for KRYSTEXXA® (pegloticase) co-administered with weekly oral methotrexate 15 mg.",
    "url": "https://finnhub.io/api/news?id=3eefef368875b690ccb826807774fa65362888351bfa033dd760e22723edfb1f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731618000,
      "headline": "AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024",
      "id": 131358414,
      "image": "https://media.zenfs.com/en/prnewswire.com/a085ee332e8e3e11ca5c7e5584018b12",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (NASDAQ:AMGN) today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., Nov. 14-19, 2024. New data showcase reduction in disease activity by UPLIZNA® (inebilizumab-cdon) in Immunoglobulin G4-Related Disease (IgG4-RD) and support shorter infusion times for KRYSTEXXA® (pegloticase) co-administered with weekly oral methotrexate 15 mg.",
      "url": "https://finnhub.io/api/news?id=3eefef368875b690ccb826807774fa65362888351bfa033dd760e22723edfb1f"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate",
    "summary": "AMGN says there was no connection between the administration of MariTide and bone mineral density changes.",
    "url": "https://finnhub.io/api/news?id=fa16d0ccfe669174f8c83955edfcebe5983aa40cb8f4123781340b02b5fa5555",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731614400,
      "headline": "Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate",
      "id": 131358415,
      "image": "https://media.zenfs.com/en/zacks.com/88c5b382e5e9e4ea852e01bfc1435a7b",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "AMGN says there was no connection between the administration of MariTide and bone mineral density changes.",
      "url": "https://finnhub.io/api/news?id=fa16d0ccfe669174f8c83955edfcebe5983aa40cb8f4123781340b02b5fa5555"
    }
  },
  {
    "ts": null,
    "headline": "5 Healthcare Stocks to Buy in a Beaten-Up Sector",
    "summary": "It has been a shaky time for healthcare stocks, but that only presents a buying opportunity.  The  Health Care Select Sector SPDR Fund  which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September.  Investors have been selling healthcare stocks, buying up more economically-sensitive ones instead, as the Federal Reserve has cut interest rates and the market accounts for the positive economic consequences from Republicans winning the White House and both chambers of Congress.",
    "url": "https://finnhub.io/api/news?id=4d43b62abf62a0a77f6d4a384ab6fde494be8b5a52146c38beceb7e7075fb787",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731610380,
      "headline": "5 Healthcare Stocks to Buy in a Beaten-Up Sector",
      "id": 131357763,
      "image": "https://s.yimg.com/ny/api/res/1.2/QrvejPduXGfjO6QTtPWJsQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/a741676153df2123cda83c0fb107464e",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "It has been a shaky time for healthcare stocks, but that only presents a buying opportunity.  The  Health Care Select Sector SPDR Fund  which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September.  Investors have been selling healthcare stocks, buying up more economically-sensitive ones instead, as the Federal Reserve has cut interest rates and the market accounts for the positive economic consequences from Republicans winning the White House and both chambers of Congress.",
      "url": "https://finnhub.io/api/news?id=4d43b62abf62a0a77f6d4a384ab6fde494be8b5a52146c38beceb7e7075fb787"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=4545097f5cf18604450ce68f765230c217912b890818d2e0d7c0fc0399a5ef5d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731602280,
      "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "id": 131415635,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=4545097f5cf18604450ce68f765230c217912b890818d2e0d7c0fc0399a5ef5d"
    }
  },
  {
    "ts": null,
    "headline": "2 Dividend Stocks to Buy Hand Over Fist in November",
    "summary": "These companies have solid businesses and excellent dividend growth track records.",
    "url": "https://finnhub.io/api/news?id=2f826d3cfb75dfab1f1d576691ad5874d08a70dc59dcdff5206cbac376b608c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731597300,
      "headline": "2 Dividend Stocks to Buy Hand Over Fist in November",
      "id": 131358417,
      "image": "https://g.foolcdn.com/editorial/images/797409/pharmacist-talking-to-patient.jpg",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "These companies have solid businesses and excellent dividend growth track records.",
      "url": "https://finnhub.io/api/news?id=2f826d3cfb75dfab1f1d576691ad5874d08a70dc59dcdff5206cbac376b608c8"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 238-point fall led by losses in UnitedHealth, Salesforce shares",
    "summary": "Dow's 238-point fall led by losses in UnitedHealth, Salesforce shares",
    "url": "https://finnhub.io/api/news?id=9922a13fcb898da35a4fc9b46b12c33e3103b268311278c44b5ab6ef3ed2bbf9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731596820,
      "headline": "Dow's 238-point fall led by losses in UnitedHealth, Salesforce shares",
      "id": 131413567,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow's 238-point fall led by losses in UnitedHealth, Salesforce shares",
      "url": "https://finnhub.io/api/news?id=9922a13fcb898da35a4fc9b46b12c33e3103b268311278c44b5ab6ef3ed2bbf9"
    }
  },
  {
    "ts": null,
    "headline": "Citi initiates coverage on 5 new biotech stocks",
    "summary": "Investing.com -- Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB), Gilead (NASDAQ:GILD), Regeneron (NASDAQ:REGN), and Vertex (NASDAQ:VRTX).",
    "url": "https://finnhub.io/api/news?id=2f718d9f8051ba228518a6bfcb6a3d3cad58019f54abc513adba387c2f4bd164",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731596084,
      "headline": "Citi initiates coverage on 5 new biotech stocks",
      "id": 131350566,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Investing.com -- Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB), Gilead (NASDAQ:GILD), Regeneron (NASDAQ:REGN), and Vertex (NASDAQ:VRTX).",
      "url": "https://finnhub.io/api/news?id=2f718d9f8051ba228518a6bfcb6a3d3cad58019f54abc513adba387c2f4bd164"
    }
  },
  {
    "ts": null,
    "headline": "Amgen speaks out about bone density concerns with obesity drug",
    "summary": "Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data spreadsheet.",
    "url": "https://finnhub.io/api/news?id=f05bbcbe48730729306c58df7bc6275cf5809c5a74ff2150c26531d5b24936ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731591291,
      "headline": "Amgen speaks out about bone density concerns with obesity drug",
      "id": 131358419,
      "image": "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/11/shutterstock_1953872293.jpg",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data spreadsheet.",
      "url": "https://finnhub.io/api/news?id=f05bbcbe48730729306c58df7bc6275cf5809c5a74ff2150c26531d5b24936ab"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 111-point drop led by losses for Salesforce, Cisco stocks",
    "summary": "Dow's 111-point drop led by losses for Salesforce, Cisco stocks",
    "url": "https://finnhub.io/api/news?id=51ab6d4d14711a55adfc7561046e1f39acb3c1c91c7151f4c3963582714bc744",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731585720,
      "headline": "Dow's 111-point drop led by losses for Salesforce, Cisco stocks",
      "id": 131413568,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow's 111-point drop led by losses for Salesforce, Cisco stocks",
      "url": "https://finnhub.io/api/news?id=51ab6d4d14711a55adfc7561046e1f39acb3c1c91c7151f4c3963582714bc744"
    }
  }
]